Seres Therapeutics Inc (NAS:MCRB)
$ 0.7589 -0.017 (-2.19%) Market Cap: 114.94 Mil Enterprise Value: 221.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Seres Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 03:20PM GMT
Release Date Price: $19.7 (+1.13%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Hello, and welcome, everybody. My name is Chris Shibutani. I'm a member of the Goldman Sachs biotech equity research group. Welcome to our 42nd Annual Healthcare Conference, virtual this year, hopefully, live next year. We're very pleased to have Seres Therapeutics join us for the presentation. As you can see from all the panes that we have just about everybody from the C-suite. Nobody is doing any work other than with us for the next hour. So we'll try to make sure we get the most of everybody's time.

Joining us, and I have my little cheat sheet here is Eric Shaff, who's the President and CEO; David Arkowitz, who is the recently appointed Chief Financial Officer. David, welcome to this craziness. Lisa von Moltke, who is the Chief Medical Officer; Terri Young, Chief Commercial and Strategic Officer; and Matt Henn, who is the Chief Scientific Officer. Often in the wings, probably biting his nails, worried is Carlo Tanzi from Investor Relations. So we'll give Carlo a quick shout out even though he's not on camera. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot